GSK plc GSK
NYSE GSK
$46.50 -0.02 (-0.04%)
At close: Oct 9, 2026 · 4:00 PM EDT

Gsk (GSK) Long-Term Investments (2009 - 2026)

Updated

Gsk (GSK) reported Long-Term Investments of $1.34 million for the quarter ended Jun 30, 2026, down 95.0% from $26.68 million a year earlier and down 0.5% from the prior quarter.

Analysis

Gsk (GSK) Long-Term Investments (2009 - 2026) Analysis & Trends

As of Dec 31, 2025, Gsk posted Long-Term Investments of $11.87 million, down 55.8% from the prior year.

  • Long-Term Investments has declined for seven consecutive years, with a five-year compound annual growth rate of -34.7% (years ended Dec 2020 to Dec 2025).
  • By year, Long-Term Investments came in at $26.84 million in the year ended Dec 31, 2024 (-48.6%), $52.24 million in the year ended Dec 31, 2023 (-37.0%), $82.92 million in the year ended Dec 31, 2022 (-1.2%) and $83.93 million in the year ended Dec 31, 2021 (-16.2%).
  • The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Long-Term Investments since the quarter ended Dec 31, 2022.
  • Year over year, Long-Term Investments has now declined in each of the last four quarters, with an average decline of 51.6% over the last eight quarters.
  • The high point for year-over-year Long-Term Investments in five years was the quarter ended Jun 30, 2023 (growth of 69.1%); the low point was the quarter ended Mar 31, 2022 (a decline of 98.4%).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $1.35 million (quarter ended Mar 31, 2026), $11.97 million (quarter ended Dec 31, 2025) and $13.49 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn -
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn 266.00 Mn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn 297.00 Mn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn -
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn -
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn 1.56 Bn
10 Gsk 100.33 Bn 81.91 Bn 8.24 Bn 135.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 135.51 Mn
Mar 31, 2026 133.47 Mn
Dec 31, 2025 118.38 Mn
Sep 30, 2025 174.07 Mn
Jun 30, 2025 117.40 Mn
Mar 31, 2025 124.69 Mn
Dec 31, 2024 123.22 Mn
Sep 30, 2024 105.24 Mn
Jun 30, 2024 66.90 Mn
Mar 31, 2024 58.35 Mn
Dec 31, 2023 68.26 Mn
Sep 30, 2023 95.00 Mn
Jun 30, 2023 80.09 Mn
Mar 31, 2023 85.09 Mn
Dec 31, 2022 86.80 Mn
Sep 30, 2022 83.68 Mn
Jun 30, 2022 96.97 Mn
Mar 31, 2022 111.37 Mn
Dec 31, 2021 118.62 Mn
Sep 30, 2021 119.94 Mn
API Access

Gsk Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=GSK&period=max&api_key=YOUR_API_KEY